Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
81.10
-2.10 (-2.52%)
Mar 31, 2025, 2:37 PM CET

Pharma Mar Revenue

In the year 2024, Pharma Mar had annual revenue of 174.86M EUR with 10.56% growth. Pharma Mar had revenue of 48.36M in the quarter ending December 31, 2024, with 19.38% growth.

Revenue
174.86M
Revenue Growth
+10.56%
P/S Ratio
8.35
Revenue / Employee
349.71K
Employees
500
Market Cap
1.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024174.86M16.70M10.56%
Dec 31, 2023158.15M-38.19M-19.45%
Dec 31, 2022196.34M-33.49M-14.57%
Dec 31, 2021229.83M-40.13M-14.87%
Dec 31, 2020269.96M184.14M214.57%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.21B
Laboratorios Farmaceuticos Rovi 763.75M
Almirall 990.63M
Faes Farma 510.04M
Clínica Baviera 265.72M
Atrys Health 211.11M
Laboratorio Reig Jofre 338.90M
Oryzon Genomics 7.36M
Revenue Rankings